Correlation of ABO blood groups with treatment response and efficacy in infants with persistent pulmonary hypertension of the newborn treated with inhaled nitric oxide
Abstract Objective Not all infants with persistent pulmonary hypertension of the newborn (PPHN) respond to inhaled nitric oxide (iNO) therapy, as it is known to improve oxygenation in only 50% to 60% of cases. In this study, we investigated whether ABO blood groups were a relevant factor affecting t...
Saved in:
Main Authors: | Yi Guan (Author), Ya Jin (Author), Yongxue Lu (Author), Dang Ao (Author), Pingjiao Gu (Author), Jiyan Yang (Author), Guosheng Liu (Author), Shasha Han (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Beyond the inhaled nitric oxide in persistent pulmonary hypertension of the newborn
by: Mei-Yin Lai, et al.
Published: (2018) -
Inhaled nitric oxide for neonates with persistent pulmonary hypertension of the newborn in the CINRGI study: time to treatment response
by: Leif D. Nelin, et al.
Published: (2019) -
The Impact of Combined Oral Sildenafil and Inhaled Nitric Oxide for Treating Persistent Pulmonary Hypertension of the Newborn: A Single Center Experience
by: Hayriye Gozde Kanmaz, et al.
Published: (2017) -
Clinical Status of Inhaled Nitric Oxide Treatment in Infants with Persistent Pulmonary Hypertension of the Newborn in Korea: Post-Marketing Surveillance Results
by: Jaewook Ha, et al.
Published: (2020) -
THE NURSING CARE IN OXIDE NITRIC THERAPY IN NEWBORN WITH PULMONARY HYPERTENSION PERSISTENT
by: Jordana Angélica Rohr, et al.
Published: (2010)